Description
This episode of Talk Liver to Me explores the practical use of resmetirom and semaglutide in MASH, based on the 2026 EASL–EASD–EASO Guidance. Experts discuss who may benefit from treatment, when to initiate therapy, and how to monitor response and efficacy in clinical practice.
Host: Debbie Shawcross (EASL)
Guests: Andrea Ciudin (EASO), Amelia Gastaldelli (EASD) Frank Tacke (EASL)
Talk Liver To Me is supported by Boehringer Ingelheim, GSK, IPSEN and Opella. Sponsors have had no input to the content of this programme.